Literatur
- 1
Andrew M, David M, Adams M. et al .
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian
registry of VTE.
Blood.
1994;
83
1251-1257
- 2
Schmidt B, Andrew M.
Neonatal thrombosis: report of a prospective Canadian and international registry.
Pediatrics.
1995;
96
939-943
- 3
Nowak-Göttl U, Kries R von, Göbel U.
Neonatal symptomatic thromboembolism in Germany: two year survey.
Arch Dis Child Fetal Neonatal Ed.
1997;
76
F163-F167
- 4
Van Ommen C H, Heijboer H, Büller H R. et al .
Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands.
J Pediatr.
2001;
139
676-681
- 5
Young G, Albisetti M, Bonduel M. et al .
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic
review and meta-analysis of observational studies.
Circulation.
2008;
118
1373-1382
- 6
Kenet G, Lütkhoff L K, Albisetti M. et al .
Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous
thrombosis in neonates and children: a systematic review and meta-analysis of observational
studies.
Circulation.
2010;
121
1838-1847
- 7
Kries R von, Junker R, Oberle D. et al .
Foetal growth restriction in children with prothrombotic risk factors.
Thromb Haemost.
2001;
86
1012-1016
- 8
Petäjä J, Hiltunen L, Fellman V.
Increased risk of intraventricular hemorrhage in preterm infants with thrombophilia.
Ped Res.
2001;
49
643-646
- 9
Berkun Y, Padeh S, Barash J. et al .
Antiphospholipid syndrome and recurrent thrombosis in children.
Arthritis Rheum.
2006;
55
850-855
- 10
Avcin T, Cimaz R, Silverman E D. et al .
Pediatric antiphospholipid syndrome: clinical and immunological features of 121 patients
in an international registry.
Pediatrics.
2008;
122
e1100-e1107
- 11
Male C, Chait P, Ginsberg J S. et al .
Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein
thrombosis in the upper body in children: Results of the PARKAA study.
Thromb Haemost.
2002;
87(4)
593-598
- 12
Tormene D, Simioni S, Prandoni P. et al .
The incidence of venous thromboembolism in thrombophilic children: a prospective cohort
study.
Blood.
2002;
100
2403-2405
- 13
Dietrich J E, Hertweck S P, Perlman S E.
Efficacy of familial history in determining thrombophilia risk.
J Pediatr Adolesc Gynecol.
2007;
20
221-224
- 14
Andrew M.
The relevance of developmental hemostasis to hemorrhagic disorders of newborns.
Sem Perinatol.
1997;
21
70-85
- 15
Monagle P, Chalmers E, Chan A. et al .
Antithrombotic therapy in neonates and children: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest.
2008;
133 (6 Suppl.)
887S-968S
- 16
Ignjatovic V, Najid S, Newall F. et al .
Dosing and monitoring of enoxaparin (low molecular weight heparin) therapy in children.
Br J Haematol.
2010;
149
734-738
- 17
Marlar R A, Mongomery R R, Broekmans A W.
Diagnosis and treatment of homozygous protein C-deficiency. Report of the Working
Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein
S. International Committee on Thrombosis and Haemostasis.
J Pediatr.
1989;
114
528-534
- 18
Farnoux C, Camard O, Pinquier D. et al .
Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates.
J Pediatr.
1998;
133
137-140
- 19
Weiner G M, Castle V P, DiPietro M A. et al .
Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen
activator.
J Pediatr.
1998;
133
133-136
- 20
Schmugge M, Risch L, Huber A R. et al .
Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care
patients.
Pediatrics.
2002;
109
U69-U72
- 21
Zöhrer B, Zenz W, Rettenbacher A. et al .
Danaparoid sodium (OrgaranR) in four children with heparin-induced thrombocytopenia
type II.
Acta Paediatr.
2001;
90
765-771
- 22
Monagle P, Adams M, Mahoney M. et al .
Outcome of pediatric thromboembolic disease: a report from the Canadian childhood
thrombophilia registry.
Pediatr Res.
2000;
47
763-766
- 23
Häusler M, Hübner D, Delhaas T. et al .
Long term complications of inferior vena cava thrombosis.
Arch Dis Child.
2001;
85
228-233
- 24
Nowak-Göttl U, Junker R, Kreuz W. et al .
Risk of recurrent thrombosis in children with combined prothrombotic risk factors.
Blood.
2001;
97
858-862
- 25
Kreuz W, Stoll M, Junker R. et al .
Familial elevated factor VIII in children with symptomatic venous thrombosis and post-thrombotic
syndrome: results of a multicenter study.
Arterioscler Thromb Vasc Biol.
2006;
26
1901-1906
- 26
Young G, Becker S, Düring C. et al .
Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic
recurrent venous thromboembolism in children: an international multicenter cohort
study.
J Thromb Haemost .
2009;
7
72-79
- 27
Kenet G, Kirkham F, Niederstadt T. et al .
Risk factors for recurrent venous thromboembolism in the European collaborative paediatric
database on cerebral venous thrombosis: a multicentre cohort study.
Lancet Neurol.
2007;
6
595-603
- 28
Morag I, Epelman M, Daneman A. et al .
Portal vein thrombosis in the neonate: risk factors, course, and outcome.
J Pediatr.
2006;
148
735-739
- 29
Chan V HT, Monagle P, Massicotte P. et al .
Novel paediatric anticoagulants: a review of the current literature.
Blood Coagul Fibrinolysis.
2010;
21
144-151
- 30
Encke A, Haas S, Sauerland S. et al .
S3-Leitlinie Prophylaxe der venösen Thromboembolie (VTE).
Vasa.
2009;
38 (Suppl.)
17-65
Dr. Daniela Manner
Institut für Klinische Chemie
Universitätsklinikum Schleswig-Holstein
Campus Lübeck
Ratzeburger Allee 160
23538 Lübeck
Telefon: 0451/5004391
Fax: 0451/5004849
eMail: Daniela.Manner@uk-sh.de
